Natural active ingredients, terameprocol and quercetin, were found to enhance the sensitivity of NSCLC cells to radiation therapy and exert inhibitory effect on prostate cancer cells via inhibiting Sp1 [33, 34]. This evidence concerns the gene SP1 and prostate carcinoma.